Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
BIOMAKERS logo — Empowering Therapies with Precision Data

BIOMAKERS

Empowering Therapies with Precision Data

Founded 2014 United States San Francisco, United States 68 employees Biopharma, Biotechnology +2

General Information

Company Name BIOMAKERS
Founded Year 2014
Location United States San Francisco, United States +4
Employees 68
Industries Biopharma, Biotechnology, Health and Wellness +1
Social

Get notified when BIOMAKERS moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About BIOMAKERS

BIOMAKERS is a global Precision Medicine Company focused on producing complex & advanced genomic data + RWE for cancer and rare diseases, aiming to extend the lifespan of cancer patients and revolutionize data-driven Drug Development in oncology worldwide. The company has developed a groundbreaking platform that facilitates Diagnosis, Treatment, Drug Development, Target discovery, and AI for Cancer and Rare Diseases. With products spanning the 4 Stages of the Biopharmaceutical chain, BIOMAKERS offers a vast range of genomic and molecular Testing services for cancer & rare disease patients across +17 countries in Latin America. Since its establishment in 2014, BIOMAKERS has rapidly emerged as a leader in Precision Medicine in the region. The company has created the largest multinational Advanced Tumor Biobank and Cancer Dataset in LATAM, and operates fully owned Sequencing Labs in Mexico, Brazil, and Argentina, with additional operations in the USA. This has positioned BIOMAKERS as a significant player in the global Oncology Drug Development Landscape. BIOMAKERS operates in the Biopharma, Biotechnology, Health and Wellness, and Clean Energy sectors, signaling diverse applications for its genomic and molecular testing services. Notably, the company has not disclosed its last investment details, including the investors and the investment amount. Nevertheless, its progress and impact in the genomics and precision medicine space are indicative of its potential for future growth and investment opportunities.

Taxonomy: Precision Medicine, Genomic Analysis, Cancer Research, Rare Diseases, Tumor Biobank, Molecular Testing, Drug Development, Genomic Data Analysis, Pharmacogenetics, Hereditary Diseases, Oncology, AI for Cancer, Biopharmaceutical, Sequencing Labs

No funding data available for BIOMAKERS yet.

Get notified when BIOMAKERS raises funding

BIOMAKERS Alternatives & Competitors

BIOMAKERS vs
Xcoo
Xcoo Japan

Genomic Intelligence Based on Advanced Computing, Chrovis

14 employees
BIOMAKERS vs
The ISOPROG-Somatolink EPFP Research Network
The ISOPROG-Somatolink EPFP Research Network United States

Life-saving research and innovation

4 employees
BIOMAKERS vs
Lantern Pharma Inc. (Nasdaq: LTRN)
Lantern Pharma Inc. (Nasdaq: LTRN) United States

Leveraging Artificial Intelligence to Rescue and Develop Cancer Therapies

Post Ipo Secondary
28 employees
AI, Biopharma
Compare BIOMAKERS vs Lantern Pharma Inc. (Nasdaq: LTRN)

FAQ About BIOMAKERS

Empowering Therapies with Precision Data
BIOMAKERS was founded in 2014.
BIOMAKERS is headquartered in San Francisco, United States.
BIOMAKERS operates in the following industries: Biopharma, Biotechnology, Health and Wellness, Clean Energy.
BIOMAKERS has approximately 68 employees.
Top alternatives and competitors to BIOMAKERS include Xcoo, The ISOPROG-Somatolink EPFP Research Network, Lantern Pharma Inc. (Nasdaq: LTRN), Genomenon, Inc, Adela, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BIOMAKERS and Xcoo are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors BIOMAKERS and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy